EPIRUS Biopharmaceuticals, Inc. Finite-Lived Intangible Assets, Net
EPIRUS Biopharmaceuticals, Inc. had Finite-Lived Intangible Assets, Net of $6.21 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2016-05-10
- 2016-03-31: Finite-Lived Intangible Assets, Net $6.21M.
- 2015-12-31: Finite-Lived Intangible Assets, Net $6.41M.
- 2015-09-30: Finite-Lived Intangible Assets, Net $5.42M.
- 2015-06-30: Finite-Lived Intangible Assets, Net $3.49M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2016-03-31 | $6.21M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $6.41M 10-Q · filed 2016-05-10 |
| 2015-09-30 | $5.42M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $3.49M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $3.55M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $3.60M 10-K · filed 2016-03-29 |
| 2014-09-30 | $3.66M 10-Q · filed 2014-11-10 |
| 2013-12-31 | $7.20M 10-Q · filed 2014-08-11 |
| 2013-09-30 | $11.11M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $13.29M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $15.47M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $17.65M 10-K · filed 2014-03-14 |
| 2012-09-30 | $18.63M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $19.60M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $20.57M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $21.55M 10-K · filed 2013-03-07 |
| 2011-09-30 | $22.83M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $24.12M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $26.69M 10-K · filed 2012-03-09 |